China, which now conducts more clinical drug trials than the US, still lags in the quality and commercial reach of its biomedical science, according to a recent survey of senior US leaders in industry and academia. The poll, conducted by Cure Innovation Index, found that China is seen as the cl...
Source: [SCMP](https://www.scmp.com/news/world/united-states-canada/article/3357975/china-closing-us-leads-biotech-quality-and-commercial-reach-survey-finds?utm_source=rss_feed)